NEW YORK (GenomeWeb) – BioView announced on Wednesday that the US Food and Drug Administration has cleared for marketing the firm's Duet System to detect rearrangements involving the ALK gene in non-small cell lung cancer samples.

Specifically, the system has been cleared for the qualitative detection of ALK rearrangements via fluorescence in situ hybridization in formalin-fixed paraffin-embedded NSCLC tissue specimens that are probed with the Abbott Vysis ALK Break Apart FISH Probe Kit.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Oct
23
Sponsored by
PerkinElmer

This webinar will address a range of methods for optimizing small RNA library preparation.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Nov
29
Sponsored by
Schott

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.